Peripheral neuropathy in adolescents and young adults with type 1 and type 2 diabetes from the SEARCH for diabetes in youth follow-up cohort: A pilot study

Diabetes Care

Volumn 36, Issue 12, 2013, Pages 3903-3908

  Jaiswal, Mamta ^a   Lauer, Abigail ^b   Martin, Catherine L ^c   Bell, Ronny A ^b   Divers, Jasmin ^b   Dabelea, Dana ^d   Pettitt, David J ^e   Saydah, Sharon ^f   Pihoker, Catherine ^g   Standifordn, Debra A ^h   Rodriguez, Beatriz L ⁱ   Pop Busui, Rodica ^c   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Global Health and Health Disparities   (United States)

^e SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^f NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; DIABETIC PERIPHERAL NEUROPATHY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE DURATION; ELEVATED BLOOD PRESSURE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICHIGAN NEUROPATHY SCREENING INSTRUMENT; MICHIGAN NEUROPATHY SCREENING INSTRUMENT EXAM; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PILOT STUDY; PREVALENCE; SENESCENCE; WAIST CIRCUMFERENCE; BLOOD; CLINICAL TRIAL; COMPLICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FOLLOW UP; HEALTH SURVEY; METABOLISM; MULTICENTER STUDY; PROCEDURES; RISK FACTOR; UNITED STATES; YOUNG ADULT;

ADOLESCENT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; PILOT PROJECTS; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84891856633     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-1213     Document Type: Article

References (24)

1. Patterson CC, Gyürüs E, Rosenbauer J, et al. Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 2012;55: 2142-2147
2. Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silink M; Consensus Workshop Group. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care 2004;27:1798-1811
3. Imperatore G, Boyle JP, Thompson TJ, et al.; SEARCH for Diabetes in Youth Study Group. Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care 2012;35:2515-2520
4. Boulton AJ, Vinik AI, Arezzo JC, et al.; American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005;28:956-962
5. Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996;39:1377-1384
6. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-154
7. Katulanda P, Ranasinghe P, Jayawardena R, Constantine GR, Sheriff MH, Matthews DR. The prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country. Diabetol Metab Syndr 2012;4:21
8. Albers JW, Herman WH, Pop-Busui R, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care 2010;33:1090-1096
9. Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, et al.; DCCT/EDIC Research Group. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation 2009;119:2886-2893
10. American Diabetes Association. Standards of medical care in diabetesd2012. Diabetes Care 2012;35(Suppl. 1):S11-S63
11. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281-1289
12. Moghtaderi A, Bakhshipour A, Rashidi H. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy. Clin Neurol Neurosurg 2006;108:477-481
13. Herman WH, Pop-Busui R, Braffett BH, et al.; DCCT/EDIC Research Group. Use of the Michigan Neuropathy Screening Instrument as ameasure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med 2012;29:937-944
14. SEARCH Study Group. SEARCH for Diabetes in Youth: amulticenter study of the prevalence, incidence and classification of diabetes mellitus in youth. Control Clin Trials 2004;25:458-471
15. Eppens MC, Craig ME, Cusumano J, et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 2006;29: 1300-1306
16. Olsen BS, Sjølie A, Hougaard P, et al.; Danish Study Group of Diabetes in Childhood. A 6-year nationwide cohort study of glycaemic control in young people with type 1 diabetes. Risk markers for the development of retinopathy, nephropathy and neuropathy. J Diabetes Complications 2000;14:295-300
17. Nery Ferreira BE, Silva IN, de Oliveira JT. High prevalence of diabetic polyneuropathy in a group of Brazilian children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2005;18:1087-1094
18. Tesfaye S, Chaturvedi N, Eaton SE, et al.; EURODIAB Prospective Complications Study Group. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005 27;352:341-350
19. Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A; KORA Study Group. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care 2008;31:464-469
20. Maser RE, Steenkiste AR, Dorman JS, et al.; Report from Pittsburgh Epidemiology of Diabetes Complications Study. Epidemiological correlates of diabetic neuropathy. Diabetes 1989;38:1456-1461
21. Forrest KY, Maser RE, Pambianco G, Becker DJ, Orchard TJ. Hypertension as a risk factor for diabetic neuropathy: a prospective study. Diabetes 1997;46:665-670
22. Cho YH, Craig ME, Hing S, et al. Microvascular complications assessment in adolescents with 2-to 5-yr duration of type 1 diabetes from 1990 to 2006. Pediatr Diabetes 2011;12:682-689
23. Olsen BS, Johannesen J, Sjølie AK, et al.; Danish Study Group of Diabetes in Childhood. Metabolic control and prevalence of microvascular complications in young Danish patientswith Type 1 diabetes mellitus. Diabet Med 1999;16:79-85
24. American Diabetes Association. Executive summary: Standards of medical care in diabetesd 2012. Diabetes Care 2012;35 (Suppl. 1):S4-S10